PPT-PrEP Facts

Clinical trials have shown daily oral Tenofovir to effectively prevent HIV acquisition PrEP must only be prescribed for HIV patients and patients taking PrEP must have regular tests for HIV and other clinical conditions . Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP+ . WEBINAR: What does PrEP mean for. people living with HIV: science, policy. and . implementation?. . Date: Thursday, 30th July 2015. Time: 4pm CET. New Drugs and Delivery Systems. Roy M. Gulick, MD, MPH. Chief, Division of Infectious Diseases. Professor of Medicine. Weill Medical College of Cornell University. New York City. Criteria for PrEP. Safe. Know the indications and contraindications of various prep types.. Describe prepping patterns for various body sites. know where to find guidelines for use of various surgical preps.. Objectives. The Purpose of the prep is to render the surgical site as free as possible from infectious organisms.. Ecole. Franco-. Australienne. de Brisbane. Teachers. Teresa . Raciti. – Principal . Anita Heinrich – Deputy Principal. Sarah Abbott – Head of Curriculum/Librarian. Jessica Gounder – Prep G Monday Tuesday. Providers in Clinical Settings. 2. Welcome!. Please sign the registration sheet.. Please make a name tag for yourself.. Please take a participant’s folder. . Any component of this document may be reproduced or adapted without prior permission from ICAP, provided that: 1) ICAP is acknowledged; 2) appropriate attribution is given for all changes that are made; and 3) the material is made available free of charge. . Susanne Doblecki-Lewis, MD. Associate Professor of Clinical Medicine. Division of Infectious Diseases. University of Miami Miller School of Medicine. November 30, 2016. Biomedical HIV Prevention. …. Up in Kenya: . Bridge . to . Scale . Project. IAS Satellite . Session. 25. th. . July . 2017. Dr. Elizabeth . Irungu. Partners Scale up Project, Kenya . Dr. Daniel Were. Jhpiego, Kenya . Background on HIV in Kenya . Bridge . to . Scale . Project. IAS Satellite . Session. 25. th. . July . 2017. Dr. Elizabeth . Irungu. Partners Scale up Project, Kenya . Dr. Daniel Were. Jhpiego, Kenya . Background on HIV in Kenya . MSM . who practice chemsex? Results from a sub-study of the ANRS-IPERGAY trial. Roux P. 1. , . Fressard. . L. 1. , . Suzan. -Monti . M. 1. , . Chas. . J. 2. , . Capitant . C. 3. , . Meyer . L. 3. , . B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Bukusi. . Kenya Medical Research Institute. University of Washington. University of California, San Franscisco . . Adherence crucial for success of any clinical drug trial and/or treatment. Robert M. Grant, M.D., M.P.H. .. IAS 2017, July 2017, Paris. Disclosures. Gilead Sciences donated study medication to US NIH for trials that I have led, including . iPrEx. , . iPrEx. OLE, and HPTN 067.. Katherine Marx, MS, MPH, FNP-BC. June 2014. Disclosure. I, Katherine Marx, have no relevant financial, professional, or personal relationships to disclose.. Objectives. Know current US recommendations for . PreP. and Prevention. IAC 2018 . Update. Lynda Dee. September 26, 2018. PrEP UP. . Town Hall Meeting. CDC: HIV Transmission Statistics. CDC: Impact of PrEP on HIV Diagnoses 2012 to 2016. 2017 TASP: Transmission in Undetectable MSM Couples.  . Review tips for telling . a partner.  . Schedule an appointment for the client and partner . if the client wants the provider’s help telling partner about PrEP use. Document that provider asked about .